End-of-day quote
Shanghai S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
8.35
CNY
|
+1.09%
|
|
+17.94%
|
-29.36%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,856
|
2,048
|
1,808
|
3,042
|
3,414
|
2,468
|
Enterprise Value (EV)
1 |
1,915
|
2,142
|
2,097
|
3,378
|
3,807
|
3,097
|
P/E ratio
|
153
x
|
338
x
|
-14.7
x
|
-37.7
x
|
356
x
|
-49.3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.49
x
|
2.64
x
|
4.26
x
|
4.94
x
|
4.28
x
|
3.1
x
|
EV / Revenue
|
2.57
x
|
2.76
x
|
4.95
x
|
5.48
x
|
4.78
x
|
3.89
x
|
EV / EBITDA
|
53.3
x
|
58.8
x
|
-21.1
x
|
-82.2
x
|
56.4
x
|
60.8
x
|
EV / FCF
|
-15.4
x
|
-55.2
x
|
-19.5
x
|
-128
x
|
182
x
|
-114
x
|
FCF Yield
|
-6.48%
|
-1.81%
|
-5.14%
|
-0.78%
|
0.55%
|
-0.88%
|
Price to Book
|
3.51
x
|
3.83
x
|
4.39
x
|
9.17
x
|
9.13
x
|
6.33
x
|
Nbr of stocks (in thousands)
|
202,000
|
202,000
|
202,000
|
202,000
|
207,560
|
208,790
|
Reference price
2 |
9.190
|
10.14
|
8.950
|
15.06
|
16.45
|
11.82
|
Announcement Date
|
4/19/19
|
4/27/20
|
4/28/21
|
4/21/22
|
4/27/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
746.4
|
777.1
|
424
|
615.9
|
797.1
|
795.8
|
EBITDA
1 |
35.92
|
36.44
|
-99.44
|
-41.11
|
67.48
|
50.97
|
EBIT
1 |
17.93
|
17.18
|
-120.4
|
-64.52
|
33.91
|
9.973
|
Operating Margin
|
2.4%
|
2.21%
|
-28.39%
|
-10.48%
|
4.25%
|
1.25%
|
Earnings before Tax (EBT)
1 |
14.86
|
3.893
|
-129
|
-82.64
|
4.272
|
-54.33
|
Net income
1 |
12.86
|
6.246
|
-122.3
|
-80.97
|
9.346
|
-48.42
|
Net margin
|
1.72%
|
0.8%
|
-28.84%
|
-13.15%
|
1.17%
|
-6.08%
|
EPS
2 |
0.0600
|
0.0300
|
-0.6100
|
-0.4000
|
0.0463
|
-0.2400
|
Free Cash Flow
1 |
-124
|
-38.81
|
-107.8
|
-26.32
|
20.96
|
-27.17
|
FCF margin
|
-16.62%
|
-4.99%
|
-25.42%
|
-4.27%
|
2.63%
|
-3.41%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
31.06%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
224.25%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/19/19
|
4/27/20
|
4/28/21
|
4/21/22
|
4/27/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
58.6
|
93.3
|
289
|
336
|
393
|
629
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.631
x
|
2.56
x
|
-2.906
x
|
-8.168
x
|
5.821
x
|
12.33
x
|
Free Cash Flow
1 |
-124
|
-38.8
|
-108
|
-26.3
|
21
|
-27.2
|
ROE (net income / shareholders' equity)
|
2.42%
|
0.75%
|
-26.3%
|
-22.2%
|
2.21%
|
-14.7%
|
ROA (Net income/ Total Assets)
|
0.89%
|
0.79%
|
-5.72%
|
-3.05%
|
1.48%
|
0.38%
|
Assets
1 |
1,443
|
790.1
|
2,139
|
2,657
|
633.5
|
-12,862
|
Book Value Per Share
2 |
2.620
|
2.640
|
2.040
|
1.640
|
1.800
|
1.870
|
Cash Flow per Share
2 |
1.020
|
0.8800
|
0.4600
|
0.6100
|
0.8900
|
0.8900
|
Capex
1 |
51.3
|
51.7
|
107
|
94.1
|
81.7
|
105
|
Capex / Sales
|
6.87%
|
6.66%
|
25.26%
|
15.28%
|
10.24%
|
13.24%
|
Announcement Date
|
4/19/19
|
4/27/20
|
4/28/21
|
4/21/22
|
4/27/23
|
4/25/24
|
|
1st Jan change
|
Capi.
|
---|
| -29.36% | 241M | | +2.80% | 103B | | +1.20% | 67.05B | | +44.29% | 40.4B | | +15.99% | 38.64B | | +3.71% | 32.41B | | +6.27% | 19.17B | | +12.32% | 16.76B | | +17.69% | 15.07B | | +8.31% | 14.82B |
Other Commodity Chemicals
|